"The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.
Excessive topical application of FABIOR Foam may lead to marked redness, peeling, or discomfort [see WARNINGS AND PRECAUTIONS]. Management of accidental ingestion or excessive application to the skin should be as clinically indicated.
FABIOR Foam is contraindicated in pregnancy.
FABIOR Foam may cause fetal harm when administered to a pregnant woman.
If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, treatment should be discontinued and the patient apprised of the potential hazard to the fetus [see WARNINGS AND PRECAUTIONS, Use In Specific Populations].
Last reviewed on RxList: 4/12/2016
Additional Fabior Information
Report Problems to the Food and Drug Administration
Find out what women really need.